Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Perioperative Pembrolizumab's Impact on Early-Stage NSCLC Survival Nov 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Anlotinib-Osimertinib Combo Shows Promise in Advanced NSCLC With EGFR T790M Mutation Nov 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab + Chemo vs Chemo in EGFR-mutated NSCLC Nov 29, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Plus Lazertinib Outperforms Osimertinib in EGFR-Mutated NSCLC Nov 29, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Nivolumab Plus Chemo Shows Promising EFS in Resectable Lung Cancer Nov 29, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Digital vs. Manual PD-L1 Tumour Cell Scoring: A Comparison Nov 29, 2023
Bladder Cancer,Gastric Cancer,Gastrointestinal Cancer,Genitourinary Cancer Promising Outcomes in Advanced Solid Tumors with Cami Alone or with Pembrolizumab Nov 29, 2023